360 High-Risk Vulnerability Immunization Tool V2.0 vs Seqrite Endpoint Protection: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Seqrite Endpoint Protection: Enterprise endpoint protection platform with ML-driven threat detection. built by Seqrite. Core capabilities include ML-driven malware and ransomware detection, Unified endpoint management console, Multi-site management with centralized policy control..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Seqrite Endpoint Protection differentiates with ML-driven malware and ransomware detection, Unified endpoint management console, Multi-site management with centralized policy control.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Seqrite Endpoint Protection is developed by Seqrite. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and Seqrite Endpoint Protection serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools, both cover Patch Management. Review the feature comparison above to determine which fits your requirements.